Global Influenza Vaccination Market -Highlights
Influenza is a contagious respiratory disease which affects the respiratory tract in humans. Symptoms of influenza include fever, headache, cough, malaise, sore throat, body aches, and nasal congestion. Vaccination against influenza is an effective way to prevent the illness.
Request Sample with Emerging Trends @ https://www.marketresearchfuture.com/sample_request/1621
Global Influenza Vaccination Market – Key Players
- Abbott (U.S.)
- AstraZeneca (Europe)
- BioCryst Pharmaceuticals, Inc. (U.S.)
- Novartis AG (Europe)
- DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
- GlaxoSmithKline plc. (Europe)
- Hualan Biological Engineering Inc (Asia Pacific)
Global Influenza Vaccination Market -Segmentation
The global influenza vaccination market is segmented on the basis of type of influenza, manufacturing technology, vaccines, and others. Basis of the type of influenza, the market is segmented into seasonal, pandemic, zoonotic, and others.
Based on the manufacturing technology, the market is segmented into egg based, cell culture based, recombination based technology, and others. On the basis of the vaccines, the market is segmented into fluzone, flumist, fluvax, fluvirin, and others.
Global Influenza Vaccination Market – Growth and Analysis
Increasing prevalence of influenza is a major driver for the market growth. Increasing immune-compromised geriatric population and rising per capita healthcare expenditure fuels the market growth during the forecast period.
Access Report Details with TOC @ https://www.marketresearchfuture.com/reports/influenza-vaccination-market-1621
Stringent regulatory framework and low accessibility of the product in the developing economies may restrain the market growth during the forecast period.
The global influenza vaccination market is expected to grow at an approximate CAGR of 8.2% during the forecast period.
On the basis of the end-users, the market is segmented into hospital & clinics, research organization, academic institutes, and others.
Global Influenza Vaccination Market – Regional Analysis
The Americas dominate the global influenza vaccination market. Increasing prevalence of influenza and high per capita healthcare expenditure are the major drivers for the American influenza vaccination market.
Europe holds the second market for influenza vaccination owing to the availability of funds for research and huge patient population.
Asia Pacific is the fastest growing region for the market. Presence of developing economies like India and China and favorable government policies along with the growing geriatric population boosts the regional market growth.
The Middle East & Africa has the least share in the global influenza vaccination market. Presence of the poor economies in the African region restrains the market growth during the forecast period. Majority of the market in the Middle & Africa region is held by the Middle East region.
Feel Free to Ask Any Query @ https://www.marketresearchfuture.com/enquiry/1621
Some Points form TOC for Influenza Vaccination Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar